SPRY2 and prostate cancer: Identifying hypermethylated CpG islands in hSpry2 gene correlated with suppressed expression of hSpry2 mRNA, they implicated epigenetic inactivation as the main mechanism for the hSpry2 downregulation in prostate cancer.